Urokinase-type plasminogen activator (uPA) augments inflammation and tissue remodeling during lung injury and repair. The uPA expression in small airway epithelium of chronic obstructive pulmonary disease (COPD) increases. Epithelialmesenchymal transition (EMT) is important in the small airway fibrosis of COPD. This study shows the uPA regulation in cigarette smoke extract (CSE)-induced EMT in human small airway epithelial cell lines (HSAEpiCs). uPA is overexpressed in the small airway epithelium of COPD patients and CSE-treated cell lines. Furthermore, uPA expression correlated with vimentin expression in the small airway epithelium of COPD patients. uPA inhibition blocks CSE-induced EMT by reversing E-cadherin and a-catenin expression and retarding the induction of N-cadherin and vimentin, resulting in reduction in migration. uPA overexpression in HSAEpiC cells also promotes EMT and migration. EMT is partly reversed in uPA-overexpressing HSAEpiC cells through the silencing expression of uPA receptor. In conclusion, this study provides new insights into the contribution of uPA upregulation to EMT associated with small airway remodeling in COPD.
the reports that nAChRa1 may be an alternative classical uPAR receptor. uPA binds nAChRa1 and promotes renal fibrosis. The functional knockdown of nAChRa1 is shown to attenuate fibrosis significantly after ureteral obstruction, and this is a uPA-dependent effect. 11 uPA deficiency reduces fibrosis in a heart damaged by viral myocarditis or left ventricular pressure overload. An increase in uPA levels is associated with numerous pathologies, such as asthma, COPD, and interstitial lung disease. [12] [13] [14] The uPA mechanism of various actions remains incompletely understood despite the association of uPA with several activities.
We have recently shown that the uPA system affects the pathogenesis of COPD. The immunohistochemical staining of uPA and uPAR is significantly elevated in the small airway epithelia of COPD patients compared with that of the controls. 15 Gene network search analysis shows numerous pathways that are biologically plausible candidates for COPD pathogenesis. For example, plasminogen activator, urokinase (PLAU); plasminogen activator, urokinase receptor; and thrombospondin (THBS1) are three genes involved in TGFb1 activation and matrix metalloproteinases (MMPs). 16 We have recently described a pathway through which cigarette smoke extract (CSE) induces EMT in human small airway epithelial cells by increasing uPAR expression and activating uPAR-dependent cell signaling pathways. 17 We have investigated the effect and mechanism of uPA action on EMTs in human small airway epithelium of COPD patients, and explored the interaction between uPA and uPAR on EMTs.
MATERIALS AND METHODS Patients
Lung tissues were obtained from 75 patients (24 nonsmoker non-COPD patients, 25 smokers without COPD, and 26 smokers with COPD) at Qilu Hospital (Jinan, China) following lobectomy or pneumonectomy for various medical reasons. The diagnosis of COPD was made according to the guidelines of the Global Initiative for Chronic Obstructive Lung Disease. 18 No subjects received corticosteroids (oral or inhaled) before tissue collection. All experiments were approved by the ethics committee of Qilu Hospital and informed consent was obtained from all patients before specimen collection. The clinical characteristics of the patients are shown in Table 1 . All recruited patient groups were similar with regard to age. The number of pack-years was similar between smokers without COPD and smokers with COPD.
Immunohistochemistry
Serial sections (4 mM) of formalin-fixed, paraffin-embedded lung tissue were used for immunohistochemical analysis. Sections were immunostained with primary antibodies recognizing uPA (ADG3689, American Diagnostica), E-cadherin (24E10, Cell Signaling Technology), and vimentin (D21H3, Cell Signaling Technology) and visualized using the avidinbiotin-peroxidase (ABC) complex (ZhongShan Biotech, Beijing, China) method. Color development was performed using a DAB color development kit (ZhongShan Biotech). Images were captured using an OLYMPUS DP72 light microscope (Olympus, Tokyo, Japan) fitted with a SPOT camera. Image analysis was performed using Image-Pro Plus 6.0 software (Media Cybernetics, Silver Spring, MD, USA). The area of the small airway epithelia and length of the basement membrane were evaluated. uPA and E-cadherin were expressed as mean staining density in the small airway epithelia. Vimentin was expressed as the number of positive epithelial cells/mm basement membrane. All slides were analyzed in a single batch by a single experienced observer with quality assurance on randomly selected slides provided by a professional academic pathologist.
Preparation of CSE CSE was prepared using a modified method described by Aoshiba et al. 19 Briefly, one filterless commercial cigarette (13 mg of tar and 1.2 mg of nicotine per cigarette) was combusted using a modified, syringe-driven apparatus. Mainstream smoke was bubbled through 20 ml of serum-free Ham's F12 nutrient medium (F12). The resulting suspension was adjusted to pH 7.4 with concentrated NaOH and filtered through a 0.22-mm pore filter to remove bacteria and large particles. This solution (designated as a 100% CSE solution) was used within 30 min of preparation.
Cell Culture
Human small airway epithelial cells (HSAEpiCs) were obtained from ScienCell Research Laboratories (Cat. No. 3231). Cells were cultured in small airway epithelial cell medium (SAEpiCM) at 37 1C in a water-saturated atmosphere with 5% carbon dioxide. 0 ) were cloned into the pSuper vector as previously described. 5 Control oligonucleotides corresponding to the inverse uPAR shRNA sequences were also prepared. Cells were transfected with pSuper-shRNA targeting uPAR or empty vector using Lipofectamine2000. uPAR knockdown was assessed by western blotting.
Cell Migration Assay
Cell migration assay was done using Transwell (6.5-mm diameter, 8-mm pore size polycarbonate membrane) that was obtained from Corning (Cambridge, MA, USA). Cells were treated without or with 5% CSE, and 5% CSE þ 20 nmol/l amiloride before adding the cells to the top chamber (1 Â 10 5 /well). Cells were transfected with constructs encoding empty vector or uPA in the upper chamber of Transwells. F12 medium with 10% fetal bovine serum was used in the lower chamber. After 24 h, the nonmigrating cells were removed from the upper surface of each Transwell by a cotton swab. Transwell membranes were then stained with 0.5% crystal violet. Cells that migrated through the membrane to the lower surface were counted.
Real-Time Reverse Transcription-PCR Total RNA was extracted using Trizol reagent (Invitrogen) according to the manufacturer's instructions. First-strand cDNA was synthesized using SuperScript II reverse transcriptase (Invitrogen). Real-time PCR reactions were prepared using SYBR s Green Real-Time PCR Master Mix (Invitrogen) and PCR was performed with an ABI PRISM7900 HT Sequence Detection System. PCR was performed using the following primers: PLAU forward 5 0 -GCGACTCCAAAGGC AGCAATGAACT-3 0 and reverse 5 0 -TCTGCGCAGTCATGCA CCATGC-3 0 , GAPDH forward 5 0 -GCTGGCGCTGAGTACGT CGT-3 0 and reverse 5 0 -ACGTTGGCAGTGGGGACACG-3 0 . Endogenous GAPDH was used as a normalization control. Results were analyzed by the relative quantity (DDCt) method. Experiments were performed in triplicate with internal duplicate determinations.
Western Blot Analysis Cells extracts were prepared using ice-cold RIPA buffer containing complete protease inhibitor cocktail (Roche) and 1 mM sodium orthovanadate. Proteins were separated by 10% SDS-PAGE and transferred to PVDF membranes and probed with antibodies detecting human uPA, uPAR (10G7, Santa Cruz), E-cadherin, vimentin, a-catenin (610194, BD Transduction Laboratories), and N-cadherin (610920, BD Transduction Laboratories). b-Actin (4970, Cell Signaling Technology) was used as an endogenous loading control.
Statistical Analysis
The statistical software packages (Graph Pad Prism and SPSS 13.0) were used for the analysis. The Mann-Whitney U-test was used for comparisons between patient groups. Spearman's test was used for correlation analyses. When a significant difference was found, Bonferroni-corrected Mann-Whitney U-tests were used. Student's t-test was used for in vitro experiments on HSAEpiCs. All results are presented as mean ± s.e.m. The P-values of o0.05 were accepted as statistically significant.
RESULTS uPA and EMT Biomarker Expression in the Small Airway Epithelium of COPD Subjects
To explore whether uPA expression is increased in small airway epithelial cells, lung tissue samples were obtained from smokers with COPD, smokers without COPD, and nonsmoker non-COPD subjects. The uPA expression in small airway epithelium was evaluated by immunohistochemical analysis of lung sections. Figure 1a presents a representative staining pattern that shows a more intense uPA staining in the epithelium of the small airways in subjects with COPD and smokers without COPD than nonsmoker non-COPD controls, especially in COPD subjects. The quantitative analysis of uPA staining showed that the uPA expression was significantly increased in COPD when compared with nonsmoker (Po0.01) and smoker controls (Po0.01). The uPA expression was higher in smoker controls than in nonsmokers (Po0.05).
We also observed the expression of E-cadherin (Figure 2d-f and j) and vimentin ( Figure 2g -i and k) in lung sections of COPD subjects and control subjects. We observed a significant immunostaining of E-cadherin in small airway epithelial cells from a nonsmoker and a smoker, whereas E-cadherin expression was partly decreased in a COPD subject. Small airway epithelial cells from the same COPD subject and from the same smoker had significant expression of vimentin and uPA. Vimentin-positive cells were increased in the epithelium of small airways in COPD patients when compared with controls. In contrast, E-cadherin staining was significantly reduced in the small airway epithelia of patients with COPD compared with controls.
Correlations
We have assessed whether the uPA expression in small airways is correlated with FEV 1 % or vimentin expression in the small airways. No correlation was observed between the uPA expression in the small airways and FEV 1 % (Figure 3a-c) . The correlation analyses show that uPA expression in small airways was correlated with vimentin expression in the 
Increased uPA Expression in CSE-Induced HSAEpiC Cells
We previously demonstrated that activation of uPARdependent cell signaling promoted EMT of HSAEpiCs by CSE. The uPA interacts with its receptor, uPAR, to regulate migration, chemotaxis, and cytokine production. 20 Therefore, we tested whether uPA was upregulated in CSEinduced HSAEpiCs. To address this question, we incubated these cells with different concentrations of CSE for 72 h and analyzed uPA expression at both mRNA and protein levels. HSAEpiC cells had dose-dependent mRNA and protein expression of uPA in response to stimulation with different concentrations of CSE (Figure 4a and b) . HSAEpiC cells were later incubated with 5% CSE for 0 to 72 h and then uPA mRNA and protein was measured by real-time PCR and western blotting. Figure 4c and d showed that CSE induced uPA expression in a time-dependent manner. The effect becomes apparent at 48 h. In our previous study, we show that uPAR expression was increased following CSE exposure in HSAEpiC intracellular. As uPAR has multiple isoforms including a soluble form, we measured using ELISA the soluble uPA receptor (suPAR) in supernatants of different cell cultures with or without CSE treatment. The results showed that CSE could increase the level of suPAR in the super- Figure 1) . These results are consistent with our previous reports in intracellular that uPAR is increasing in CSE-induced cells. 17 
uPA Is Required for CSE-Induced EMT in HSAEpiC Cells
To test whether uPA is responsible for CSE-induced EMT, we treated HSAEpiC cells with 20 nmol/l amiloride (for uPA inhibition). Figure 5a shows that after 72 h with 5% CSE, HSAEpiC cells, which typically appear epithelial with welldeveloped cell junctions, acquired a spindle shape and generally lost cell contacts. Amiloride preserved epithelial cell morphology and cell contacts in HSAEpiC cells that were exposed to CSE, as determined by phase-contrast imaging. As expected, the CSE-mediated EMT was observed in HSAEpiC cells treated with CSE. We exposed HSAEpiC cells to 5% CSE for 72 h. These cells demonstrated increased N-cadherin and vimentin expression and loss of E-cadherin and a-catenin. HSAEpiC cells underwent EMT, as determined by western blotting. Figure 5b shows that in the presence of both amiloride and CSE, cells had increased levels of E-cadherin and a-catenin and decreased levels of N-cadherin and vimentin expression as compared with control cells treated with CSE.
Exposure of HSAEpiC cells to CSE promotes cell migration. To test whether CSE-induced cell migration is reversed by amiloride, we examined it by Transwell assays. Figure 5c shows that the amiloride inhibited the increase in cell migration observed in HSAEpiC cells treated with CSE alone (Po0.01).
uPA Overexpression Induces EMT in HSAEpiC Cells
Although the data presented thus far indicated that uPA was necessary for EMT in CSE-induced HSAEpiC cells, we wished We hypothesized that uPA may be necessary for morphologic and molecular parameters of EMT. To test this hypothesis, we used uPA-overexpressing and control HSAEpiC cells. Phase-contrast imaging of uPA-overexpressing HSAEpiC cells revealed loss of cell contacts and they acquired a spindle shape (Figure 6b ). uPA-overexpressing cells induced expression of vimentin and decreased E-cadherin expression, as determined by western blotting (Figure 6c ). Figure 6d shows that transient transfection with uPA increased cell migration compared with control cells (Po0.01). These results indicated that uPA overexpression independently induced EMT in HSAEpiC cells, without exposure to CSE.
uPAR Gene Silencing Reverses EMT in uPA-Overexpressing HSAEpiC Cells uPA binding to uPAR is necessary for leading to an extracellular protease cascade implicated in mechanisms including cell migration, MMP activation, and intracellular signaling molecules. 21, 22 We hypothesized that endogenous production of uPAR in uPA-overexpressing HSAEpiC cells may be necessary to sustain EMT. To test this hypothesis, we transfected uPA-overexpressing and control HSAEpiC cells with the uPAR shRNA silencing vector, pSuper-shuPAR. Control cells were transfected with empty vector (pSuper). uPAR protein expression was measured 48 h later. As shown in Figure 7a -c, uPA-overexpressing cells that were transfected without or with pSuper demonstrated increased levels of uPAR protein compared with control empty vector cells. pSuper-shuPAR decreased uPAR protein expression compared with control uPA-overexpressing cells (Po0.01). pSuper-shuPAR also partially decreased vimentin protein expression and increased E-cadherin protein expression compared with control uPA-overexpressing cells (Po0.01), suggesting that uPAR gene silencing may partly reverse uPAmediated EMT (Figure 7d-f) .
DISCUSSION
We hypothesized that a predisposition to altered uPA expression may be associated with EMT in COPD. Through a series of controls and individuals with COPD, we showed that uPA expression is increased in the bronchioles of subjects with COPD, particularly in the epithelium. The relationship between uPA expression in the epithelium and small airway remodeling requires further investigation, but relating epithelial histology to uPA expression in a crosssectional study would be difficult to interpret. Our previous studies found that uPA staining increased in the small airway 15 This study is the first to investigate the uPA protein expression ex vivo in the small airways of a number of control and COPD individuals. These findings provide a basis for further investigation of the role of uPA in the epithelium. Using cultured human HSAEpiC cells, we have shown that alteration in the uPA pathway is one cause of small airway fibrosis in COPD pathology.
COPD is a complex condition of both airway and lung parenchymal components, and is caused by the persistent inhalation of toxic particles and gases that are primarily but not exclusively derived from tobacco smoke. 23 It is of interest that different regions respond in different ways; for example, the small conducting airways o2 mm in diameter become the major site of airway obstruction in COPD. 24 In contrast, dilatation and destruction of the gas-exchanging tissues beyond the terminal bronchioles define emphysematous destruction of the lung. The new data based on micro-CT imaging indicate that both narrowing and reduction in the number of terminal bronchioles contribute to the rapid decline in FEV 1 , leading to severe airway obstruction in COPD. 25 Moreover, the observation that terminal bronchiolar changes before the onset of emphysematous destruction suggests that this destruction begins in the early stages of COPD. EMT is associated with fibrosis that occurs in the lung tissues. 26 EMTrelated changes are described in other chronic epithelial stress, and are also present in the airway epithelia of COPD. 3, 27 Several signaling factors have emerged as mediators of EMT that is associated with small airway fibrosis in COPD. Previous data support the hypothesis that TGF-b1 induced by CSE activates Smad3 and ERK1/2, contributing to the EMT process in differentiated human bronchial epithelial cells. 27 We have recently shown that increased uPAR expression in the small airway epithelium of COPD patients participates in an active EMT process modulated by PI3K/ Akt and GSK3b. 17 uPAR is a glycosyl phosphatidylinositolanchored protein with a high affinity to uPA. The uPAR expression and its ability to bind uPA are required for signaling. 28 To the best of our knowledge, the possibility of achieving this EMT process by uPA has not been previously addressed. Therefore, we aim to determine whether uPA contributed to EMT in small airway epithelium in COPD.
Some cancer cells demonstrate an increased uPA in EMT process, but do not elaborate its effects to EMT. 29 In our study, the increasing expression of uPA was caused by exposure to CSE. In addition, amiloride, a uPA inhibitor, signifi- These data showed that uPA regulated the process of EMT in the small airway epithelial cell line. The ability of uPA to markedly induce EMT in HSAEpiC cells in vitro and the increased expression of uPA in small airways of COPD subjects demonstrate an intricate link between airway remodeling and uPA pathway and potentially substantial pathophysiological significance.
In lung (patho) physiology, uPA augments inflammation and tissue remodeling. 30 Targeting uPA to treat inflammation and tissue remodeling in respiratory disease is less developed, and there is scant preclinical evidence regarding the likely effectiveness of this approach. Shetty et al 31 showed that uPAmediated induction of TF occurs in lung epithelial cells to promote increased fibrin deposition in the airways during acute lung injury. Enhancing uPA/plasmin activity lessens the airway remodeling in a murine asthma model. 32 This remains the case, even though there is compelling evidence of uPA involvement in tissue remodeling, and uPA has attracted attention as an emerging therapeutic target in cancer. 33 Genetic studies have also shown an essential role of uPA in tissue healing or regeneration. For example, the loss of uPA impaired scar formation, because wound fibroblasts were unable to activate the fibrogenic TGF-b1. Using phage display technology, Liang et al 34 reported putative uPA-binding consensus sequences in 12 transmembrane receptors and suggested them as candidate alternative uPA receptors. Among these candidate receptors, several are already known as uPAR co-receptors: low-density lipoprotein receptor-related protein, gp130, integrin av, uPAR-associated protein (also known as Endo180 and Mrc2), and the insulin-like growth factor II/mannose 6-phosphate receptor. It is also possible that different uPA domains might simultaneously bind to uPAR and one of its co-receptors. 35 Based on this information, a role for uPAR with uPA signaling, however, cannot be excluded. The elevated levels of uPAR in small airway epithelia and alveolar wall cells were also observed in COPD patients with a significant emphysema in our previous study. 15 Lungs from uPAR( À / À ) mice displayed nonspecific interstitial pneumonia-like pathological features, with a significant increase in alveolar septal width and collagen content. 36 These studies suggest that downregulation of uPAR may be related with interstitial pulmonary fibrosis; however, the uPAR-initiated EMT in small airway of COPD patients may be accounting for small airway fibrosis in COPD. It is of interest that this phenomenon may be associated with pathological characteristics of different regions in COPD. In the present study we investigated the effect of uPA on EMT by downregulation of uPAR expression. The effect of uPA involved in the EMT of the cultured HSAEpiCs was partly dependent on the presence of uPAR. The results presented in this study suggest that in cell culture, induction of EMT by uPA requires that the small airway epithelial cells not only express high levels of uPA but also uPAR, so that uPAR is ligated and uPARdependent cell signaling is activated. If this pathway is operational, then activation of uPA/uPAR-dependent EMT may represent a novel mechanism by which the small airway epithelial cell microenvironment affects airway remodeling progression.
In summary, in this study we have made the observation that small airway epithelial cells express uPA by immunohistology. The potential disease relevance of uPA expression in the small airway epithelium is suggested from our studies demonstrating that uPA is highly expressed in the small airways of COPD subjects and correlates with the expression of vimentin in small airways of smokers and COPD groups. Further studies in vitro showed high levels of uPA induced by CSE in HSAEpiCs that may be responsible for CSE-induced EMT. Upon silencing of uPAR gene in uPA-overexpressing HSAEpiC cells, the uPA-induced EMT is reduced. Overall, these studies suggest that uPA expression by small airway epithelium may modulate the small airway remodeling in COPD through EMT.
